Recent Blog Articles

Heart Health

Lessons from the blood pressure drug recall

May 01, 2019

Here's what you need to know about the discovery of contaminants in a popular class of heart medications.


Last summer, a number of prescription medications containing the generic drug valsartan were recalled by manufacturers after investigators found trace amounts of possible cancer-causing impurities in some of the products. Over the following months, additional lots of valsartan, as well as batches of two similar drugs, losartan and irbesartan, were also pulled from pharmacy shelves.

All three of these drugs belong to a class of medications known as angiotensin-receptor blockers, or ARBs. These drugs block the effects of a hormone that narrows blood vessels and are used to treat high blood pressure and heart failure. The recalled products also include combination drugs that contain one of those three ARBs. (See "Medication recall information" for accessing the list of affected products.)

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.